DNDN Mgt shall unplug Partnership atleast if not buyout ....DOUBLE DIGITS ASSURED
Shorts still think they control this issue but long minded are returning. I'm holding DNDN, watching for signs of a turn around. It once traded in the 50's. While those days seem over, if DNDN management can turn things around with new catalysts and stream lining efforts underway, double digit share levels may return.
It's got potential in my view because Provenge is FDA approved and European approval is looking more likely. As the therapy gains traction, DNDN improves efficiency, streamlines operations and more positive results become known - DNDN may just climb out of the hole it seems to have dug for itself.